Articles in section Mergers & Acquisitions
| << Licensing | 725 articles | Opinion & Analysis >> |
| Pages 1 2 3 4 5 .. 73 | Next >> |
-
Merck KGaA Acquires Bio-Techne for up to US$11.3 B
-
Jazz Pharmaceuticals Expands Rare Epilepsy Portfolio with US$1.32 B Acquisition of Actio Biosciences
-
Tarsus Pharmaceuticals Expands Eye Care Portfolio with Acquisition of Alkeus Pharmaceuticals
-
Supernus and Indivior Merge to Create a CNS-Focused Drug Company
-
Argenx to Acquire Forte Biosciences for US$2.2 B
-
Novartis Expands Oncology Portfolio with US$1.5 B Acquisition of Myricx
-
Lilly to Acquire AtaiBeckley to Advance Therapies Targeting Resistant Depression and Other Mental Health Conditions for US$3.8 B
-
Vertex to Acquire Crinetics Pharmaceuticals for US$10 B
-
Ipsen Expands Rare Disease Portfolio with US$1 B+ Acquisition of Memo Therapeutics
-
AbbVie Deepens Immunology Leadership with US$10.9 B Acquisition of Apogee Therapeutics
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS